시장보고서

상품코드

1842373

동물용 진정제 시장 규모, 점유율, 동향 분석 보고서 : 용도별, 동물 유형별, 투여 경로별, 약물 종류별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Animal Sedative Market Size, Share & Trends Analysis Report By Application, By Animal Type, By Route Of Administration (Parenteral, Oral), By Drug Class, By End Use, By Region, And Segment Forecasts, 2025 - 2033

발행일: 2025년 09월 | 리서치사:

Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

동물용 진정제 시장 요약

세계 동물용 진정제 시장 규모는 2024년에 2억 2,700만 달러로 추정되며, 2033년에는 3억 8,100만 달러에 달할 것으로 예상되며, 2025년부터 2033년까지 6.04%의 CAGR로 성장할 것으로 예상됩니다.

이 시장은 축산업과 육류 생산의 성장, 수의외과 수술 및 진단 절차의 확대, 수의약리학 및 의약품 개발의 발전으로 발전하고 있습니다.

축산 부문은 또 다른 강력한 시장 성장 촉진요인입니다. 육류, 유제품, 가금류 제품에 대한 전 세계적인 수요가 증가함에 따라 진정제는 소, 말, 돼지와 같은 대형 동물의 스트레스를 관리하고 운송을 용이하게 하며 취급의 안전성을 향상시키기 위해 널리 사용되고 있습니다.

진정제는 스트레스로 인한 체중 감소를 억제하고, 번식 관리를 개선하며, 축산 사업의 전반적인 생산성을 향상시킵니다. 또한, 동물 복지에 대한 정부의 노력과 인도적 취급에 관한 규정은 진정제의 책임감 있는 사용을 장려하고 있습니다. 세계 식량 수요를 충족시키기 위해 축산업이 강화됨에 따라 효과적이고 안전한 진정제 솔루션에 대한 수요는 꾸준히 증가할 것으로 예상됩니다.

시장 계통 전망
- 상부 시장
- 보조 시장
시장 역학
- 시장 성장 촉진요인 분석
- 시장 성장 억제요인 분석
- 시장 기회 분석
- 시장 과제 분석
동물용 진정제 시장 분석 툴
- 업계 분석 - Porter's Five Forces 분석
- PESTEL 분석
- 규제 프레임워크
- 가격 분석
- 2024년 주요 국가 및 주요 종별 동물 추정 개체수

제4장 동물용 진정제 시장 : 용도 추정·동향 분석

부문 대시보드
동물용 진정제 시장 : 용도 변동 분석
동물용 진정제 시장 규모와 동향 분석(용도별, 2021-2033년)
- 외과수술
- 진단
- 안락사
- 기타

제5장 동물용 진정제 시장 : 동물 유형 추정·동향 분석

부문 대시보드
동물용 진정제 시장 : 동물 유형 변동 분석
동물용 진정제 시장 규모와 동향 분석(동물 유형별, 2021-2033년)
- 개
- 고양이
- 말
- 기타

제6장 동물용 진정제 시장 : 투여 경로 추정·동향 분석

부문 대시보드
동물용 진정제 시장 : 투여 경로 변동 분석
동물용 진정제 시장 규모와 동향 분석(투여 경로별, 2021-2033년)
- 비경구
- 경구

제7장 동물용 진정제 시장 : 약물 클래스 추정·동향 분석

부문 대시보드
동물용 진정제 시장 : 약물 종류 변동 분석
동물용 진정제 시장 규모와 동향 분석(약물 종류별, 2021-2033년)
- 페노티아진
- 벤조디아제핀
- α2 아드레날린 수용체 작용제
- 부티로페논
- 기타

제8장 동물용 진정제 시장 : 최종 용도 추정·동향 분석

부문 대시보드
동물용 진정제 시장 : 최종 용도 변동 분석
동물용 진정제 시장 규모와 동향 분석(최종 용도별, 2021-2033년)
- 동물 병원·클리닉
- 전문 센터
- 기타

제9장 동물용 진정제 시장 : 지역별 추정·동향 분석

지역 대시보드
동물용 진정제 시장 점유율(지역별, 2024년 및 2033년)
지역 전망
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트
- 카타르
- 오만

제10장 경쟁 구도

시장 진입 기업 분류
기업의 시장 포지션 분석/히트맵 분석
기업 개요
- Zoetis Services LLC
- Virbac.
- Ouro Fino Saude Animal Group
- Dechra
- Merck & Co., Inc.
- Bimeda Inc.
- vetcar e.fi.
- Chanelle Pharma
- Randlab Australia Pty Ltd.
- Troy Laboratories Pty Ltd
전략 매핑
- 인수합병
- 파트너십과 협업
- 제품/서비스 발매
- 기타

KSM 25.10.30

Animal Sedative Market Summary

The global animal sedative market size was estimated at USD 227.0 million in 2024 and is projected to reach USD 381.0 million by 2033, growing at a CAGR of 6.04% from 2025 to 2033. The market is progressing, driven by growth in the livestock industry and meat production, expansion of veterinary surgical and diagnostic procedures, and advances in veterinary pharmacology and drug development.

The livestock sector represents another strong market growth driver. Along with increasing global demand for meat, dairy, and poultry products, sedatives are widely used to manage stress, facilitate transportation, and improve handling safety in large animals like cattle, horses, and pigs.

Sedation reduces stress-related weight loss, improves reproduction management, and enhances overall productivity in livestock operations. Additionally, government initiatives for animal welfare and regulations around humane handling are encouraging the responsible use of sedatives. As livestock farming intensifies to meet global food needs, the demand for effective and safe sedative solutions is expected to rise steadily.

Global Animal Sedative Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the animal sedative market report based on application, animal, route of administration, drug class, end use, and region:

Application Outlook (Revenue, USD Million, 2021 - 2033)
Surgical
Diagnostic
Euthanasia
Others
Animal Outlook (Revenue, USD Million, 2021 - 2033)
Dogs
Cats
Horses
Others
Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
Parenteral
Oral
Drug Class Outlook (Revenue, USD Million, 2021 - 2033)
Phenothiazines
Benzodiazepines
Alpha-2 Adrenergic Receptor Agonists
Butyrophenones
Others
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Veterinary Hospitals & Clinics
Specialty Centers
Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- India
- China
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Qatar
- Oman

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources
- 1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
- 1.7.1. Commodity flow analysis
- 1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Animal Sedative Market Variable Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market
- 3.1.2. Ancillary Market
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Increasing Pet Ownership
  - 3.2.1.2. Rising Prevalence Of Chronic Diseases In Animals
  - 3.2.1.3. Increasing Animal Health Expenditure
  - 3.2.1.4. Rising Surgical Procedures
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Stringent regulations
  - 3.2.2.2. Side effects associated with sedatives
  - 3.2.2.3. Lack of Skilled Professionals
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
3.3. Animal Sedative Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Bargaining power of suppliers
  - 3.3.1.2. Bargaining power of buyers
  - 3.3.1.3. Threat of substitution
  - 3.3.1.4. Threat of new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political & Legal landscape
  - 3.3.2.2. Economic and Social landscape
  - 3.3.2.3. Technological landscape
  - 3.3.2.4. Environmental landscape
- 3.3.3. Regulatory Framework
- 3.3.4. Pricing Analysis
- 3.3.5. Estimated Animal Population, by key countries & key species, 2024

Chapter 4. Animal Sedative Market: Application Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Animal Sedative Market: Application Movement Analysis
4.3. Animal Sedative Market Size & Trend Analysis, by application, 2021 to 2033 (USD Million)
4.4. Surgical
- 4.4.1. Surgical Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Diagnostic
- 4.5.1. Diagnostic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Euthanasia
- 4.6.1. Euthanasia Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Others
- 4.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Animal Sedative Market: Animal Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Animal Sedative Market: Animal Movement Analysis
5.3. Animal Sedative Market Size & Trend Analysis, by Animal, 2021 to 2033 (USD Million)
5.4. Dogs
- 5.4.1. Dogs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Cats
- 5.5.1. Cats Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Horses
- 5.6.1. Horses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Others
- 5.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Animal Sedative Market: Route of Administration Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Animal Sedative Market: By Route of Administration Movement Analysis
6.3. Animal Sedative Market Size & Trend Analysis, by Route of Administration, 2021 to 2033 (USD Million)
- 6.3.1. Parenteral
  - 6.3.1.1. Parenteral Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.2. Oral
  - 6.3.2.1. Oral Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Animal Sedative Market: Drug Class Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Animal Sedative Market: Drug Class Movement Analysis
7.3. Animal Sedative Market Size & Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
7.4. Phenothiazines
- 7.4.1. Phenothiazines Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Benzodiazepines
- 7.5.1. Benzodiazepines Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Alpha-2 Adrenergic Receptor Agonists
- 7.6.1. Alpha-2 Adrenergic Receptor Agonists Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Butyrophenones
- 7.7.1. Butyrophenones Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8. Others
- 7.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Animal Sedative Market: End Use Estimates & Trend Analysis

8.1. Segment Dashboard
8.2. Animal Sedative Market: By End Use Movement Analysis
8.3. Animal Sedative Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 8.3.1. Veterinary Hospitals & Clinics
  - 8.3.1.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.2. Specialty Centres
  - 8.3.2.1. Specialty Centres Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.3. Others
  - 8.3.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Animal Sedative Market: Regional Estimates & Trend Analysis

9.1. Regional Dashboard
9.2. Animal Sedative Market Share, By Region, 2024 & 2033, USD Million
9.3. Regional Outlook
9.4. North America
- 9.4.1. North America Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.4.2. U.S.
  - 9.4.2.1. Key Country Dynamics
  - 9.4.2.2. Competitive Scenario
  - 9.4.2.3. U.S. Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.4.3. Canada
  - 9.4.3.1. Key Country Dynamics
  - 9.4.3.2. Competitive Scenario
  - 9.4.3.3. Canada Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.4.4. Mexico
  - 9.4.4.1. Key Country Dynamics
  - 9.4.4.2. Competitive Scenario
  - 9.4.4.3. Mexico Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
9.5. Europe
- 9.5.1. Europe Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.5.2. UK
  - 9.5.2.1. Key Country Dynamics
  - 9.5.2.2. Competitive Scenario
  - 9.5.2.3. UK Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.5.3. Germany
  - 9.5.3.1. Key Country Dynamics
  - 9.5.3.2. Competitive Scenario
  - 9.5.3.3. Germany Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.5.4. France
  - 9.5.4.1. Key Country Dynamics
  - 9.5.4.2. Competitive Scenario
  - 9.5.4.3. France Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.5.5. Italy
  - 9.5.5.1. Key Country Dynamics
  - 9.5.5.2. Competitive Scenario
  - 9.5.5.3. Italy Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.5.6. Spain
  - 9.5.6.1. Key Country Dynamics
  - 9.5.6.2. Competitive Scenario
  - 9.5.6.3. Spain Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.5.7. Denmark
  - 9.5.7.1. Key Country Dynamics
  - 9.5.7.2. Competitive Scenario
  - 9.5.7.3. Denmark Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.5.8. Sweden
  - 9.5.8.1. Key Country Dynamics
  - 9.5.8.2. Competitive Scenario
  - 9.5.8.3. Sweden Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.5.9. Norway
  - 9.5.9.1. Key Country Dynamics
  - 9.5.9.2. Competitive Scenario
  - 9.5.9.3. Norway Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
9.6. Asia Pacific
- 9.6.1. Asia Pacific Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.6.2. Japan
  - 9.6.2.1. Key Country Dynamics
  - 9.6.2.2. Competitive Scenario
  - 9.6.2.3. Japan Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.6.3. China
  - 9.6.3.1. Key Country Dynamics
  - 9.6.3.2. Competitive Scenario
  - 9.6.3.3. China Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.6.4. India
  - 9.6.4.1. Key Country Dynamics
  - 9.6.4.2. Competitive Scenario
  - 9.6.4.3. India Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.6.5. Australia
  - 9.6.5.1. Key Country Dynamics
  - 9.6.5.2. Competitive Scenario
  - 9.6.5.3. Australia Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.6.6. South Korea
  - 9.6.6.1. Key Country Dynamics
  - 9.6.6.2. Competitive Scenario
  - 9.6.6.3. South Korea Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.6.7. Thailand
  - 9.6.7.1. Key Country Dynamics
  - 9.6.7.2. Competitive Scenario
  - 9.6.7.3. Thailand Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
9.7. Latin America
- 9.7.1. Latin America Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.7.2. Brazil
  - 9.7.2.1. Key Country Dynamics
  - 9.7.2.2. Competitive Scenario
  - 9.7.2.3. Brazil Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.7.3. Argentina
  - 9.7.3.1. Key Country Dynamics
  - 9.7.3.2. Competitive Scenario
  - 9.7.3.3. Argentina Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
9.8. Middle East & Africa
- 9.8.1. Middle East & Africa Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.8.2. South Africa
  - 9.8.2.1. Key Country Dynamics
  - 9.8.2.2. Competitive Scenario
  - 9.8.2.3. South Africa Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.8.3. Saudi Arabia
  - 9.8.3.1. Key Country Dynamics
  - 9.8.3.2. Competitive Scenario
  - 9.8.3.3. Saudi Arabia Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.8.4. UAE
  - 9.8.4.1. Key Country Dynamics
  - 9.8.4.2. Competitive Scenario
  - 9.8.4.3. UAE Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.8.5. Kuwait
  - 9.8.5.1. Key Country Dynamics
  - 9.8.5.2. Competitive Scenario
  - 9.8.5.3. Kuwait Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.8.6. Qatar
  - 9.8.6.1. Key Country Dynamics
  - 9.8.6.2. Competitive Scenario
  - 9.8.6.3. Qatar Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 9.8.7. Oman
  - 9.8.7.1. Key Country Dynamics
  - 9.8.7.2. Competitive Scenario
  - 9.8.7.3. Oman Animal Sedative Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

10.1. Market Participant Categorization
10.2. Company Market Position Analysis/ Heat Map Analysis
10.3. Company Profiles
- 10.3.1. Zoetis Services LLC
  - 10.3.1.1. Participant's Overview
  - 10.3.1.2. Financial Performance
  - 10.3.1.3. Product Benchmarking
  - 10.3.1.4. Strategic Initiatives
- 10.3.2. Virbac.
  - 10.3.2.1. Participant's Overview
  - 10.3.2.2. Financial Performance
  - 10.3.2.3. Product Benchmarking
  - 10.3.2.4. Strategic Initiatives
- 10.3.3. Ouro Fino Saude Animal Group
  - 10.3.3.1. Participant's Overview
  - 10.3.3.2. Financial Performance
  - 10.3.3.3. Product Benchmarking
  - 10.3.3.4. Strategic Initiatives
- 10.3.4. Dechra
  - 10.3.4.1. Participant's Overview
  - 10.3.4.2. Financial Performance
  - 10.3.4.3. Product Benchmarking
  - 10.3.4.4. Strategic Initiatives
- 10.3.5. Merck & Co., Inc.
  - 10.3.5.1. Participant's Overview
  - 10.3.5.2. Financial Performance
  - 10.3.5.3. Product Benchmarking
  - 10.3.5.4. Strategic Initiatives
- 10.3.6. Bimeda Inc.
  - 10.3.6.1. Participant's Overview
  - 10.3.6.2. Financial Performance
  - 10.3.6.3. Product Benchmarking
  - 10.3.6.4. Strategic Initiatives
- 10.3.7. vetcar e.fi.
  - 10.3.7.1. Participant's Overview
  - 10.3.7.2. Financial Performance
  - 10.3.7.3. Product Benchmarking
  - 10.3.7.4. Strategic Initiatives
- 10.3.8. Chanelle Pharma
  - 10.3.8.1. Participant's Overview
  - 10.3.8.2. Financial Performance
  - 10.3.8.3. Product Benchmarking
  - 10.3.8.4. Strategic Initiatives
- 10.3.9. Randlab Australia Pty Ltd.
  - 10.3.9.1. Participant's Overview
  - 10.3.9.2. Financial Performance
  - 10.3.9.3. Product Benchmarking
  - 10.3.9.4. Strategic Initiatives
- 10.3.10. Troy Laboratories Pty Ltd
  - 10.3.10.1. Participant's Overview
  - 10.3.10.2. Financial Performance
  - 10.3.10.3. Product Benchmarking
  - 10.3.10.4. Strategic Initiatives
10.4. Strategy Mapping
- 10.4.1. Mergers & Acquisitions
- 10.4.2. Partnerships & Collaborations
- 10.4.3. Product/ Service launch
- 10.4.4. Others